Diffrential expression of transforming growth factor-β and its receptors in hepatocytes and nonparenchymal cells of rat liver after CCl4 administration

Journal of Hepatology

Volumn 28, Issue 4, 1998, Pages 572-581

  Date, Masataka ^a   Matsuzaki, Koichi ^a   Matsushita, Masanori ^a   Sakitani, Kazushige ^a   Shibano, Kayo ^a   Okajima, Ai ^a   Yamamoto, ^a   Ogata, Nahoko ^a   Okumura, Tadayoshi ^a   Seki, Toshihito ^a   Kubota, Yoshitsugu ^a   Kan, Mikio ^b   McKeehan, Wallace L ^b   Inoue, Kyoichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Albert B Alkek Inst Biosci T   (United States)

Author keywords

Liver fibrosis; Liver regeneration; TGF ; TGF receptor

Indexed keywords

RNA POLYMERASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GROWTH INHIBITION; IN SITU HYBRIDIZATION; LIVER CELL; LIVER FIBROSIS; LIVER REGENERATION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; INTOXICATION; LIVER; MALE; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CARBON TETRACHLORIDE POISONING; DOWN-REGULATION; IN SITU HYBRIDIZATION; LIVER; LIVER REGENERATION; MALE; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031596719     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80280-8     Document Type: Article

References (47)

1. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor β Biochem Biophys Acta. 1032:1990;79-87.
2. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol. 119:1992;1017-1021.
3. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGFβ typeII receptor, a functional transmembrane serine/threonine kinase. Cell. 68:1992;775-785.
4. Mathews LS, Vale WW. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell. 65:1991;973-982.
5. Matsuzaki K, Xu J, Wang F, McKeehan WL, Krummen L, Kan M. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor β, or bone morphogenic factor. J Biol Chem. 268:1993;12719-12723.
6. Xu J, Matsuzaki K, McKeehan K, Wang F, Kan M, McKeehan WL. Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly (A) addition. Proc Natl Acad Sci USA. 91:1994;7957-7961.
7. He WW, Gustafson ML, Hirobe S, Donahoe PK. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-β type II receptor family. Dev Dyn. 196:1993;133-142.
8. ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, et al. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene. 8:1993;2879-2887.
9. Franzén P, ten Dijke P, Yamashita H, Schulz P, Heldin C-H, Miyazono K. Cloning of a TGFβ type I receptor that forms heteromeric complex with the TGFβ type II receptor. Cell. 75:1993;681-692.
10. Matsuzaki K, Kan M, McKeehan WL. Ligand-dependent and independent interactions in assembly of a pentameric transforming growth factor beta receptor complex. In Vitro. Cell Devel Biol. 32:1996;345-360.
11. Xu J, McKeehan K, Matsuzaki K, McKeehan WL. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J Biol Chem. 270:1995;6308-6313.
12. ten Dijke P, Yamashita H, Ichijo H, Franzén P, Laiho M, Miyazono K, Heldin C-H. Characterization of type I receptors for transforming growth factor-β and activin. Science. 204:1994;101-104.
13. Inagaki M, Moustakas A, Lin HY, Lodish HF, Carr BI. Growth inhibitor by transforming growth factor β (TGF-β) is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. PRoc Natl Acad Sci USA. 90:1993;5359-5363.
14. Attisano L, Wrana JL, López-Casillas F, Massagué J. TGF-β receptors and actions. Biochem Biophys Acta. 1222:1994;71-80.
15. Miyazono K, ten Dijke P, Yamashita H, Heldin C-H. Signal transduction via serine/threonine kinase receptors. Semin Cell Biol. 5:1994;389-398.
16. Wang X-F, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. Expression cloning and characterization of the TGFβ type III receptor. Cell. 67:1991;797-805.
17. López-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massagué J. Structure and expression of the membrane proteoglycan betaglycan a component of the TGF-β receptor system. Cell. 67:1991;785-795.
18. Michalopoulos GK. Control mechanism of liver regeneration. J Gastroenterol. 29:1994;23-29. (Suppl VII).
19. Fausto N, Laird AD, Webber EM. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 9:1995;1527-1536.
20. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 10:1994;1286-1292.
21. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Res. 46:1986;2330-2334.
22. Russell WE, Coffey RJ, Ouellette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA. 85:1988;5126-5130.
23. Bedossa P, Paradis V. Transforming growth factor-β (TGF-β): a key role in liver fibrogenesis. J Hepatol. 22:1995;37-42. (Suppl. 2).
24. Nakatsukasa H, Evarts RP, Hsia C, Thorgeirsson SS. Transforming growth factor-β1 and type I procollagen transcripts during regeneration and early fibrosis in rat liver. Lab Invest. 63:1990;171-180.
25. Ehrinpreis MN, Giambrone MA, Rojkind M. Liver proline oxidase activity and collagen synthesis in rats with cirrhosis induced by carbon tetrachloride. Biochem Biophys Acta. 629:1980;184-193.
26. Seglen PO. Preparation of isolated rat liver cells. Method Cell Biol. 13:1976;29-83.
27. 2 in a primary culture of adult rat hepatocytes. J Biochem. 96:1984;429-436.
28. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning PCR of rat transforming growth factor β-1. Nucleic Acids Res. 18:1990;3059.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
30. Aviv H, Leader P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA. 69:1972;1408-1412.
31. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific acitivity. Anal Biochem. 132:1985;6-13.
32. Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci USA. 74:1997;5350-5354.
33. Kan M, Huang J, Mansson PE, Yasumitsu H, Carr B, McKeehan WL. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA. 86:1989;7432-7436.
34. Okajima A, Miyazawa K, Kitamura N. Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injury. Eur J Biochem. 193:1990;375-381.
35. Lindroos PM, Zarngar R, Michalopoulos GK. Hepatocyte growth factor (hepatoproietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated partial hepatectomy and tetrachloride administration. Hepatology. 13:1991;743-749.
36. Dean M, Park M, Le Beau MM, Robins TS, Diaz MO, Rowley JD, et al., The human met oncogene is related to the tyrosine, kinase oncogenes. Nature. 318:1985;385-388.
37. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Woude GFV, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
38. Ito T, Hayashi N, Horimoto M, Sasaki Y, Tanaka Y, Kaneko A, et al. Expression of the c-met/hepatocyte growth factor receptor gene during rat liver regeneration induced by carbon tetrachloride. Biochem Biophys Res Commun. 190:1993;870-874.
39. Chari RS, Price DT, Sue SR, Meyers WC, Jirtle RL. Downregulation of transforming growth factor beta receptor type I, II, and III during liver regeneration. Am J Surg. 169:1995;126-2.
40. Andres JL, Stanley K, Cheifetz S, Massagué J. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β J Cell Biol. 109:1989;3137-3145.
41. López-Casillas F, Payne HM, Andres JL, Lane WS, Massagué J. Betaglycan can act as a dual modulator of access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol. 124:1994;557-568.
42. Ignotz RA, Massagué J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 261:1986;4337-4345.
43. Laiho M, Saksela O, Andreaeon PA, Keski-Oja E. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β J Cell Biol. 103:1986;2403-2410.
44. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β J Biol Chem. 264:1989;1860-1869.
45. Kerr LD, Olashaw NE, Matrisian LM. Transforming growth factor-β1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. J Biol Chem. 263:1988;16999-17005.
46. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;1905-1912.
47. Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor β receptors of rat lipocytes during the hepatic wound healing response. J Biol Chem. 269:1994;10551-10558.